A Randomised Phase 2 Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hydroxychloroquine (Primary)
- Indications Glioblastoma; Glioma
- Focus Therapeutic Use
- 03 May 2018 Biomarkers information updated
- 14 Dec 2013 Accrual to date is 10% according to United Kingdom Clinical Research Network record.
- 23 Nov 2013 Accrual to date is 8% according to United Kingdom Clinical Research Network record.